Bremelanotide

Treatment for Hypoactive Sexual Desire Disorder (HSDD)

Injectable solution

299.00$

(per bottle usage)

Bremelanotide is a peptide used to treat premenopausal women with hypoactive sexual desire disorder (HSDD), a low sexual desire that causes distress or interpersonal difficulty, who previously had no problems with sexual desire and that occurs in any type of stimulation, situation or couple

Safety information: Read about the side effects of Bremelanotide here

Learn more about Bremelanotide

Bremelanotide treatment is in a class of medications called melanocortin receptor agonists. It works by activating certain natural substances in the brain that control mood and thinking. It does not act directly on the genitals, but rather modulates the sexual response at a central level

Take Bremelanotide before sexual activity. Use each injection at least 45 minutes before you think you will begin sexual activity. Do not use more than 1 dose in 24 hours. Do not use more than 8 doses each month

This medication is used to treat women who have not gone through menopause who have low sexual desire and are concerned about it

* No guarantees or assurances have been made regarding the outcome of any treatment or service provided for a patient. Read about the side effects and risks here, or contact us if you have any other questions

How MediHealthRX works

Our dedicated professional team are available anytime for questions or concerns throughout the entire process

FAQs

Yes, it has been tested in clinical trials with significant efficacy shown; plus, safety studies confirm its usually use over time without serious side effects or risks

Rarely, some patients may experience minor nausea or flushing; however, these symptoms typically resolve quickly without any long-term complications

Do you have any questions?

If you have any other questions and need information, you can contact us by email or call. A healthcare professional will attend to and give you support

Safety information

Read more about serious warnings and risks of taking Bremelanotide